nach oben

Erschienen in:

27.06.2020 | Affective Disorder

Anxiety, depression, and opioid misuse among adults with chronic pain: the role of emotion dysregulation

verfasst von: Andrew H. Rogers, Michael F. Orr, Justin M. Shepherd, Jafar Bakhshaie, Joseph W. Ditre, Julia D. Buckner, Michael J. Zvolensky

Erschienen in: Journal of Behavioral Medicine | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

The opioid epidemic is a significant public health concern in the United States, particularly among adults with chronic pain. Considerable research suggests that people with mental health problems, including anxiety and depression, may experience more opioid-related problems in the context of chronic pain. Yet, little work has examined potential mechanisms underyling these relations. Emotion dysregulation is one mechanistic factor that may link anxiety and depression and opioid-related problems among persons with chronic pain. Therefore, the current study examined the explanatory role of emotion dysregulation in the cross-sectional relationship between anxiety and depression problems and current opioid misuse and severity of opioid dependence among 431 adults with chronic pain who reported currently using opioid medications (74% female, M_age=38.32 years, SD = 11.11). Results indicated that emotion dysregulation explained, in part, the relationship between anxiety and depression symptoms and opioid-related problems. These findings highlight the need to further consider the role of emotion dysregulation among adults with chronic pain who use prescription opioids and experience symptoms of anxiety or depression. Future prospective research will be needed to further establish emotion dysregulation as a mechanism in anxiety/depression-opioid misuse/dependence processes.

Abelson, R. P. (1985). A variance explanation paradox: when a little is a lot. Psychological bulletin, 97(1), 129. https://doi.org/10.1007/s10865-020-00169-8.CrossRef

Aldao, A., Nolen-Hoeksema, S., & Schweizer, S. (2010). Emotion-regulation strategies across psychopathology: A meta-analytic review. Clinical Psychology Review, 30, 217–237. https://doi.org/10.1016/j.cpr.2009.11.004CrossRefPubMed

Bair, M. J., Robinson, R. L., Katon, W., & Kroenke, K. (2003). Depression and pain comorbidity: A literature review. Archives of Internal Medicine, 163, 2433–2445. https://doi.org/10.1001/archinte.163.20.2433CrossRefPubMed

Bair, M. J., Wu, J., Damush, T. M., Sutherland, J. M., & Kroenke, K. (2008). Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Psychosomatic Medicine, 70, 890–897. https://doi.org/10.1097/PSY.0b013e318185c510CrossRefPubMedPubMedCentral

Bakhshaie, J., Rogers, A. H., Kauffman, B. Y., Tran, N., Buckner, J. D., Ditre, J. W., et al. (2019). Emotion dysregulation as an explanatory factor in the relation between negative affectivity and non-medical use of opioid in a diverse young adult sample. Addictive Behaviors, 95, 103–109. https://doi.org/10.1016/j.addbeh.2019.02.025CrossRefPubMedPubMedCentral

Ballantyne, J. C., & Shin, N. S. (2008). Efficacy of opioids for chronic pain: A review of the evidence. The Clinical Journal of Pain, 24, 469–478. https://doi.org/10.1097/AJP.0b013e31816b2f26CrossRefPubMed

Benningfield, M. M., Dietrich, M. S., Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., et al. (2012). Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes. Addiction (Abingdon, England), 107, 74–82. https://doi.org/10.1111/j.1360-0443.2012.04041.xCrossRef

Bjureberg, J., Ljótsson, B., Tull, M. T., Hedman, E., Sahlin, H., Lundh, L.-G., et al. (2016). Development and validation of a brief version of the difficulties in emotion regulation scale: The DERS-16. Journal of Psychopathology and Behavioral Assessment, 38, 284–296. https://doi.org/10.1007/s10862-015-9514-xCrossRefPubMed

Braden, J. B., Sullivan, M. D., Ray, G. T., Saunders, K., Merrill, J., Silverberg, M. J., et al. (2009). Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. General Hospital Psychiatry, 31, 564–570. https://doi.org/10.1016/j.genhosppsych.2009.07.003CrossRefPubMedPubMedCentral

Butler, S. F., Budman, S. H., Fanciullo, G. J., & Jamison, R. N. (2010). Cross validation of the current opioid misuse measure (COMM) to monitor chronic pain patients on opioid therapy. The Clinical Journal of Pain, 26, 770–776. https://doi.org/10.1097/AJP.0b013e3181f195baCrossRefPubMedPubMedCentral

Butler, S. F., Budman, S. H., Fernandez, K. C., Houle, B., Benoit, C., Katz, N., et al. (2007). Development and validation of the current opioid misuse measure. Pain, 130, 144–156. https://doi.org/10.1016/j.pain.2007.01.014CrossRefPubMedPubMedCentral

Chou, R., Turner, J. A., Devine, E. B., Hansen, R. N., Sullivan, S. D., Blazina, I., et al. (2015). The effectiveness and risks of long-term opioid therapy for chronic pain: A systematic review for a National Institutes of Health Pathways to Prevention Workshop. Annals of Internal Medicine, 162, 276–286. https://doi.org/10.7326/M14-2559CrossRefPubMed

Cisler, J. M., & Olatunji, B. O. (2012). Emotion regulation and anxiety disorders. Current Psychiatry Reports, 14, 182–187. https://doi.org/10.1007/s11920-012-0262-2CrossRefPubMedPubMedCentral

Colasanti, A., Rabiner, E., Lingford-Hughes, A., & Nutt, D. (2011). Opioids and anxiety. Journal of Psychopharmacology, 25, 1415–1433. https://doi.org/10.1177/0269881110367726CrossRefPubMed

Daubresse, M., Chang, H.-Y., Yu, Y., Viswanathan, S., Shah, N. D., Stafford, R. S., et al. (2013). Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000–2010. Medical Care, 51, 870–878. https://doi.org/10.1097/MLR.0b013e3182a95d86CrossRefPubMed

Davis, M. A., Lin, L. A., Liu, H., & Sites, B. D. (2017). Prescription opioid use among adults with mental health disorders in the United States. Journal of the American Board of Family Medicine: JABFM, 30, 407–417. https://doi.org/10.3122/jabfm.2017.04.170112CrossRefPubMed

Ditlevsen, S., Christensen, U., Lynch, J., Damsgaard, M. T., & Keiding, N. (2005). The mediation proportion: A structural equation approach for estimating the proportion of exposure effect on outcome explained by an intermediate variable. Epidemiology, 16, 114–120. https://doi.org/10.2307/20486008CrossRefPubMed

Dowell, D., Haegerich, T., & Chou, R. (2016). CDC guidelines for prescribing opioids for chronic pain: United States, 2016. MMWR Recommendations and Reports, 1, 1–49. https://doi.org/10.15585/mmwr.rr6501e1CrossRef

Farris, S. G., DiBello, A. M., & Zvolensky, M. J. (2018). Development and validation of a contextual behavioral distress intolerance task in cigarette smokers. Addictive behaviors, 87, 260–266.CrossRefPubMedPubMedCentral

Franklin, G. M., Mai, J., Turner, J., Sullivan, M., Wickizer, T., & Fulton-Kehoe, D. (2012). Bending the prescription opioid dosing and mortality curves: Impact of the Washington State opioid dosing guideline. American Journal of Industrial Medicine, 55, 325–331. https://doi.org/10.1002/ajim.21998CrossRefPubMed

Friedman, J., Kim, D., Schneberk, T., Bourgois, P., Shin, M., Celious, A., et al. (2019). Assessment of racial/ethnic and income disparities in the prescription of opioids and other controlled medications in California. JAMA Internal Medicine, 179, 469–476. https://doi.org/10.1001/jamainternmed.2018.6721CrossRefPubMedPubMedCentral

Gold, A. K., Stathopoulou, G., & Otto, M. W. (2019). Emotion regulation and motives for illicit drug use in opioid-dependent patients. Cognitive Behaviour Therapy, 0, 1–7. https://doi.org/10.1080/16506073.2019.1579256CrossRef

Gormsen, L., Rosenberg, R., Bach, F. W., & Jensen, T. S. (2010). Depression, anxiety, health-related quality of life and pain in patients with chronic fibromyalgia and neuropathic pain. European Journal of Pain, 14, 127.e1–127.e8. https://doi.org/10.1016/j.ejpain.2009.03.010CrossRef

Gossop, M., Darke, S., Griffiths, P., Hando, J., Powis, B., Hall, W., et al. (1995). The Severity of Dependence Scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction, 90, 607–614. https://doi.org/10.1111/j.1360-0443.1995.tb02199.xCrossRefPubMed

Gratz, K. L., & Roemer, L. (2004). Multidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the difficulties in emotion regulation scale. Journal of Psychopathology and Behavioral Assessment, 26, 41–54. https://doi.org/10.1023/B:JOBA.0000007455.08539.94CrossRef

Hayes, A. F. (2009). Beyond Baron and Kenny: Statistical mediation analysis in the new millennium. Communication monographs, 76(4), 408–420.CrossRef

Hayes, A. F. (2017). Introduction to mediation, moderation, and conditional process analysis: A regression-based approach. New York: Guilford Press.

Hayes, A. F., & Preacher, K. J. (2013). Conditional process modeling using structural equation modeling to examine contingent causal processes. In G. R. Hancock & R. O. Mueller (Eds.), Structural equation modeling: A second course (2nd ed., pp. 219–266). Charlotte: Information Age Publishing.

Heen, M. S., Lieberman, J. D., & Miethe, T. D. (2014). A comparison of different online sampling approaches for generating national samples. Center for Crime and Justice Policy, 1(9), 1–8.

Iraurgi Castillo, I., González Saiz, F., Lozano Rojas, O., Landabaso Vázquez, M. A., & Jiménez Lerma, J. M. (2010). Estimation of cutoff for the Severity of Dependence Scale (SDS) for opiate dependence by ROC analysis. Actas Espanolas De Psiquiatria, 38, 270–277.PubMed

Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2003). The Patient Health Questionnaire-2: validity of a two-item depression screener. Medical Care, 41, 1284–1292. https://doi.org/10.1097/01.MLR.0000093487.78664.3CCrossRefPubMed

Löwe, B., Kroenke, K., & Gräfe, K. (2005). Detecting and monitoring depression with a two-item questionnaire (PHQ-2). Journal of Psychosomatic Research, 58, 163–171. https://doi.org/10.1016/j.jpsychores.2004.09.006CrossRefPubMed

Löwe, B., Wahl, I., Rose, M., Spitzer, C., Glaesmer, H., Wingenfeld, K., et al. (2010). A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. Journal of Affective Disorders, 122, 86–95. https://doi.org/10.1016/j.jad.2009.06.019CrossRefPubMed

Lutz, J., Gross, R. T., & Vargovich, A. M. (2018). Difficulties in emotion regulation and chronic pain-related disability and opioid misuse. Addictive Behaviors, 87, 200–205. https://doi.org/10.1016/j.addbeh.2018.07.018CrossRefPubMed

Manchikanti, L., Giordano, J., Boswell, M. V., Fellows, B., Manchukonda, R., & Pampati, V. (2007). Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients. Journal of Opioid Management, 3, 89–100.CrossRefPubMed

Manchikanti, L., Helm, S., Fellows, B., Janata, J. W., Pampati, V., Grider, J. S., et al. (2012). Opioid epidemic in the United States. Pain Physician, 15, ES9–ES38.PubMed

Martins, S. S., Fenton, M. C., Keyes, K. M., Blanco, C., Zhu, H., & Storr, C. L. (2012). Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: Longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychological Medicine, 42, 1261–1272. https://doi.org/10.1017/S0033291711002145CrossRefPubMed

McEwen, B. S. (2005). Stressed or stressed out: What is the difference? Journal of Psychiatry and Neuroscience, 30, 315–318.PubMedPubMedCentral

Means-Christensen, A. J., Roy-Byrne, P. P., Sherbourne, C. D., Craske, M. G., & Stein, M. B. (2008). Relationships among pain, anxiety, and depression in primary care. Depression and Anxiety, 25, 593–600. https://doi.org/10.1002/da.20342CrossRefPubMed

Mennin, D. S., Heimberg, R. G., Turk, C. L., & Fresco, D. M. (2005). Preliminary evidence for an emotion dysregulation model of generalized anxiety disorder. Behaviour Research and Therapy, 43, 1281–1310. https://doi.org/10.1016/j.brat.2004.08.008CrossRefPubMed

Miech, R., Johnston, L., O’Malley, P. M., Keyes, K. M., & Heard, K. (2015). Prescription opioids in adolescence and future opioid misuse. Pediatrics, 136, e1169–e1177. https://doi.org/10.1542/peds.2015-1364CrossRefPubMedPubMedCentral

Murthy, V. H. (2016). Ending the opioid epidemic—A call to action. New England Journal of Medicine, 375, 2413–2415. https://doi.org/10.1056/NEJMp1612578CrossRefPubMed

Nelson, L. S., & Perrone, J. (2012). Curbing the opioid epidemic in the United States: The risk evaluation and mitigation strategy (REMS). JAMA, 308, 457–458. https://doi.org/10.1001/jama.2012.8165CrossRefPubMed

Preacher, K. J., & Hayes, A. F. (2004). SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behavior Research Methods, Instruments, and Computers, 36, 717–731. https://doi.org/10.3758/BF03206553CrossRefPubMed

Preacher, K. J., & Hayes, A. F. (2008). Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behavior Research Methods, 40, 879–891. https://doi.org/10.3758/BRM.40.3.879CrossRefPubMed

Rogers, A. H., Bakhshaie, J., Buckner, J. D., Orr, M. F., Paulus, D. J., Ditre, J. W., & Zvolensky, M. J. (2019). Opioid and cannabis co-use among adults with chronic pain: Relations to substance misuse, mental health, and pain experience. Journal of Addiction Medicine, 13(4), 287–294.CrossRefPubMed

Seal, K. H., Shi, Y., Cohen, G., Cohen, B. E., Maguen, S., Krebs, E. E., et al. (2012). Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA, 307, 940–947. https://doi.org/10.1001/jama.2012.234CrossRefPubMed

Serdarevic, M., Striley, C. W., & Cottler, L. B. (2017). Gender differences in prescription opioid use. Current Opinion in Psychiatry, 30, 238–246. https://doi.org/10.1097/YCO.0000000000000337CrossRefPubMedPubMedCentral

Stoicea, N., Costa, A., Periel, L., Uribe, A., Weaver, T., & Bergese, S. D. (2019). Current perspectives on the opioid crisis in the US healthcare system. Medicine. https://doi.org/10.1097/MD.0000000000015425CrossRefPubMedPubMedCentral

Sullivan, M. D., Edlund, M. J., Zhang, L., Unützer, J., & Wells, K. B. (2006). Association between mental health disorders, problem drug use, and regular prescription opioid use. Archives of Internal Medicine, 166, 2087–2093. https://doi.org/10.1001/archinte.166.19.2087CrossRefPubMed

Volkow, N. D., & McLellan, A. T. (2016). Opioid abuse in chronic pain—Misconceptions and mitigation strategies. New England Journal of Medicine, 374, 1253–1263. https://doi.org/10.1056/NEJMra1507771CrossRefPubMed

Von Korff, M., Ormel, J., Keefe, F. J., & Dworkin, S. F. (1992). Grading the severity of chronic pain. Pain, 50, 133–149.CrossRef

Vowles, K. E., McEntee, M. L., Julnes, P. S., Frohe, T., Ney, J. P., & van der Goes, D. N. (2015). Rates of opioid misuse, abuse, and addiction in chronic pain: A systematic review and data synthesis. Pain, 156, 569–576. https://doi.org/10.1097/01.j.pain.0000460357.01998.f1CrossRefPubMed

Walter, S. L., Seibert, S. E., Goering, D., & O’Boyle, E. H. (2019). A tale of two sample sources: Do results from online panel data and conventional data converge?. Journal of Business and Psychology, 34(4), 425–452.CrossRef

Williams, L. J., Cote, J. A., & Buckley, M. R. (1989). Lack of method variance in self-reported affect and perceptions at work: Reality or artifact? Journal of Applied Psychology, 74, 462–468. https://doi.org/10.1037/0021-9010.74.3.462CrossRef

Titel: Anxiety, depression, and opioid misuse among adults with chronic pain: the role of emotion dysregulation
verfasst von: Andrew H. Rogers
Michael F. Orr
Justin M. Shepherd
Jafar Bakhshaie
Joseph W. Ditre
Julia D. Buckner
Michael J. Zvolensky
Publikationsdatum: 27.06.2020
Verlag: Springer US
Schlagwörter: Affective Disorder
Opioids
Opioids
Affective Disorder
Anxiety
Erschienen in: Journal of Behavioral Medicine / Ausgabe 1/2021
Print ISSN: 0160-7715
Elektronische ISSN: 1573-3521
DOI: https://doi.org/10.1007/s10865-020-00169-8

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

Predictors and mediators of outcome in cognitive behavioral therapy for chronic pain: the contributions of psychological flexibility

(No) escape from reality? Cigarette craving in virtual smoking environments

No effect of mindfulness-based cancer recovery on cardiovascular or cortisol reactivity in female cancer survivors

Social Constraints and PTSD among Chinese American breast cancer survivors: not all kinds of social support provide relief